The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Shareholder Information Request

14 Apr 2023 07:00

RNS Number : 2463W
Grupo Clarin S.A.
14 April 2023
 

 

 

GRUPO CLARIN S.A.

Grupo Clarín Responds to Shareholder Request for Additional Information

 

On 12 April 2023, Grupo Clarín S.A. (the "Company") informed the Argentine Securities Commission and the Buenos Aires Stock Exchange that it had exchanged additional notes with a shareholder in connection with the agenda of the Ordinary Annual Shareholders' Meeting to be held on 25 April 2023.

 

Attached as Exhibit A is a free translation of the Company's response.

 

Enquiries:

 

In Buenos Aires:

Samantha Olivieri

Grupo Clarín

Tel: +5411 4309 7104

Email: investors@grupoclarin.com

 

In London:

Alex Money

Jasford IR

Tel: +44 20 3289 5300

Email: alexm@jasford.com

 

In New York:

Camilla Ferreira / Marcella Ewerton

Fig Corporate Communications

Tel: +1 917 691 4047

Email: fig@fig.ooo

 

 

EXHIBIT A

 

FREE TRANSLATION

 

Buenos Aires, 12 April 2023

 

Mrs.

General Directorate for Strategic and Corporate Affairs

General Director Cecilia Gonzalez Bonorino

 

Directorate of Corporate Affairs

Mrs. Paola Rolotti

National Social Security Administration (ANSES) Fondo de Garantía de Sustentabilidad

 

 

By Hand

 

 

To whom it may concern,

 

I, Samantha Lee Olivieri, in my capacity as Person Responsible for Market Relations of Grupo Clarín S.A. (hereinafter, interchangeably, the "Company" or "Grupo Clarín") hereby address You in response to your request of clarification issued by e-mail dated 12 April 2023 regarding the information provided in relation to points 3), 7) and 12) of the agenda.

 

Below, as requested, is the information requested:

 

 

3) "Consideration of the performance of the members of the Board of Directors."

 

According to the minutes of the shareholders' meeting held for the appointment of authorities on 18 April 2022 (Filing 2883592), minutes of the meeting of the Board of Directors at which positions were allocated, held on the same date (Filing 2881617), the composition of the Board of Directors of the Company during fiscal year 2022 was the following:

 

Chairman: Jorge Carlos Rendo; Vice-Chairman: Héctor Mario Aranda; Directors: Felipe Noble Herrera, Alma Rocio Aranda, Horacio Ezequiel Magnetto, Francisco Pagliaro, Alberto César Menzani, Andrés Gabriel Riportella, Horacio Eduardo Quirós and Ignacio Rolando Driollet. Alternate Directors: Francisco Iván Acevedo, Martín Gonzalo Etchevers, Patricia Miriam Colugio, Alberto Pedro Marina, Eugenio Eduardo Sosa Mendoza, Marcelo Fernando Boncagni, Carlos Rebay, Luis Germán Fernández, Lucas Puente Solari and Alfredo Enrique Kahrs.

 

7) "Consideration of the compensation of the members of the Supervisory Committee for the economic year ended 31 December 2022."

 

The amount in the Column "Proposal 2022" refers to the sum of the advancements paid, as authorised by the Shareholders in the Shareholder Meeting dated 18 April 2022, to the members of the Supervisory Committee.

 

12) "Approval of the annual budget of the Audit Committee."

 

Following is the information requested.

 

 

.

Global Amount

Ps. 1,000,000

Ps. 1,200,000

Ps. 1,500,000

Ps. 2,800,000

Nominal Increase

Ps. 100,000

Ps. 200,000

Ps. 300,000

Ps. 1,300,000

Percentage Increase

11%

20%

25%

87%

 

 

The global amounts of Ps. 1,200,000 and Ps- 1,500,000 correspond to the amounts approved for the years 2021 and 2022 respectively.

 

 

Sincerely,

 

/s/ Samantha L. Olivieri

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRIIMITMTIBMFJ
Date   Source Headline
2nd Jun 20147:38 amRNSBoard of Directors Receives Note from Shareholder
27th May 20147:57 amRNSExtraordinary Meeting of Shareholders
23rd May 20147:02 amRNSCourt of Appeals Extends Injunction
21st May 201412:59 pmRNSOffer Accepted subject to Shareholder Approval
19th May 20147:00 amRNSDividend Declaration
16th May 20147:25 amRNSBoard receives letters from certain shareholders
14th May 20144:57 pmRNSMinutes of the Meeting of the Board of Directors
12th May 20141:00 pmRNSResults for the First Quarter for 2014 (1Q14)
8th May 20145:03 pmRNSAppointment of Chairman and Vice Chairman
8th May 20142:00 pmRNSConference call and webcast: Q1 2014 Results
6th May 20147:01 amRNSAnnual Ordinary Shareholders' Meeting
2nd May 20145:08 pmRNSConference call and webcast
28th Apr 20143:22 pmRNSMinutes of the Meeting of the Board of Directors
28th Apr 20147:55 amRNSGCSA Responds to Information Request
28th Apr 20147:50 amRNSMinutes of the Meeting of the Audit Committee
28th Apr 20147:45 amRNSMinutes of the Meeting of the Board of Directors
31st Mar 20141:00 pmRNSResult of Meeting
27th Mar 20147:02 amRNSSupplementary Information on ANSES claim
26th Mar 20142:33 pmRNSHector Aranda Leave of Absence
24th Mar 20147:01 amRNSANSES brings claim against Grupo Clarin
24th Mar 20147:00 amRNSExtraordinary Shareholders' Meeting
17th Mar 20147:30 amRNSAnnual Financial Report
14th Mar 20147:02 amRNSSupreme Court Renders Decision
11th Mar 201412:55 pmRNSResults for 4Q13 and FY13
10th Mar 20147:22 amRNSGCSA Responds Shareholder Information Request
3rd Mar 20145:00 pmRNSNotice of Results
3rd Mar 20148:06 amRNSBoard of Directors Meeting Minutes
28th Feb 20143:45 pmRNSSecond Price Monitoring Extn
28th Feb 20143:40 pmRNSPrice Monitoring Extension
19th Feb 20147:02 amRNSBoard of Directors Meeting Minutes
19th Feb 20147:00 amRNSAFSCA Resolution
17th Feb 20143:45 pmRNSSecond Price Monitoring Extn
17th Feb 20143:40 pmRNSPrice Monitoring Extension
13th Feb 20143:26 pmRNSOfficial Publicity - Supreme Court Decision
10th Feb 20143:40 pmRNSPrice Monitoring Extension
29th Jan 20143:41 pmRNSGCSA makes equity contribution in subsidiary
27th Jan 20143:45 pmRNSSecond Price Monitoring Extn
27th Jan 20143:40 pmRNSPrice Monitoring Extension
24th Jan 20143:45 pmRNSSecond Price Monitoring Extn
24th Jan 20143:40 pmRNSPrice Monitoring Extension
10th Jan 20147:00 amRNSLeave of Absence requested
24th Dec 20137:00 amRNSMembers of Company Board request Leaves of Absence
6th Dec 20133:45 pmRNSSecond Price Monitoring Extn
6th Dec 20133:40 pmRNSPrice Monitoring Extension
2nd Dec 20133:45 pmRNSSecond Price Monitoring Extn
2nd Dec 20133:40 pmRNSPrice Monitoring Extension
20th Nov 20132:33 pmRNSARTEAR sells participation in Ideas del Sur S.A.
15th Nov 20132:45 pmRNSARTEAR sells participation in Ideas del Sur S.A.
12th Nov 20131:41 pmRNSRegistration of GC Dominio Effective Again
8th Nov 201312:00 pmRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.